
Cell, Год журнала: 2021, Номер 184(21), С. 5338 - 5356.e21
Опубликована: Окт. 1, 2021
Язык: Английский
Cell, Год журнала: 2021, Номер 184(21), С. 5338 - 5356.e21
Опубликована: Окт. 1, 2021
Язык: Английский
Cellular and Molecular Immunology, Год журнала: 2020, Номер 17(8), С. 807 - 821
Опубликована: Июль 1, 2020
Abstract Immunotherapy has revolutionized cancer treatment and rejuvenated the field of tumor immunology. Several types immunotherapy, including adoptive cell transfer (ACT) immune checkpoint inhibitors (ICIs), have obtained durable clinical responses, but their efficacies vary, only subsets patients can benefit from them. Immune infiltrates in microenvironment (TME) been shown to play a key role development will affect outcomes patients. Comprehensive profiling tumor-infiltrating cells would shed light on mechanisms cancer–immune evasion, thus providing opportunities for novel therapeutic strategies. However, highly heterogeneous dynamic nature TME impedes precise dissection intratumoral cells. With recent advances single-cell technologies such as RNA sequencing (scRNA-seq) mass cytometry, systematic interrogation is feasible provide insights into functional diversities In this review, we outline progress particularly by focusing landmark studies characterization tumor-associated cells, summarize phenotypic connections with immunotherapy. We believe review could strengthen our understanding facilitate elucidation modulation progression, guide immunotherapies treatment.
Язык: Английский
Процитировано
2019Nature, Год журнала: 2020, Номер 577(7791), С. 561 - 565
Опубликована: Янв. 15, 2020
Язык: Английский
Процитировано
1723Nature, Год журнала: 2020, Номер 577(7791), С. 556 - 560
Опубликована: Янв. 15, 2020
Soft-tissue sarcomas represent a heterogeneous group of cancer, with more than 50 histological subtypes1,2. The clinical presentation patients different subtypes is often atypical, and responses to therapies such as immune checkpoint blockade vary widely3,4. To explain this variability, here we study gene expression profiles in 608 tumours across soft-tissue sarcoma. We establish an immune-based classification on the basis composition tumour microenvironment identify five distinct phenotypes: immune-low (A B), immune-high (D E), highly vascularized (C) groups. In situ analysis independent validation cohort shows that class E was characterized by presence tertiary lymphoid structures contain T cells follicular dendritic are particularly rich B cells. strongest prognostic factor even context high or low CD8+ cytotoxic contents. class-E demonstrated improved survival response rate PD1 pembrolizumab phase 2 trial. Together, work confirms sarcoma, unravels potential B-cell-rich guide decision-making treatments, which could have broader applications other diseases. Immune profiling sarcoma identifies levels B-cell infiltration therapy.
Язык: Английский
Процитировано
1531Nature reviews. Cancer, Год журнала: 2020, Номер 20(11), С. 662 - 680
Опубликована: Авг. 4, 2020
Язык: Английский
Процитировано
1205Cell, Год журнала: 2021, Номер 184(21), С. 5309 - 5337
Опубликована: Окт. 1, 2021
Язык: Английский
Процитировано
1070Cell, Год журнала: 2020, Номер 182(4), С. 1044 - 1061.e18
Опубликована: Авг. 1, 2020
Язык: Английский
Процитировано
939Cell, Год журнала: 2020, Номер 182(5), С. 1341 - 1359.e19
Опубликована: Авг. 6, 2020
Antitumoral immunity requires organized, spatially nuanced interactions between components of the immune tumor microenvironment (iTME). Understanding this coordinated behavior in effective versus ineffective control will advance immunotherapies. We re-engineered co-detection by indexing (CODEX) for paraffin-embedded tissue microarrays, enabling simultaneous profiling 140 regions from 35 advanced-stage colorectal cancer (CRC) patients with 56 protein markers. identified nine conserved, distinct cellular neighborhoods (CNs)—a collection characteristic CRC iTME. Enrichment PD-1+CD4+ T cells only within a granulocyte CN positively correlated survival high-risk patient subset. Coupling and CNs, fragmentation cell macrophage disruption inter-CN communication was associated inferior outcomes. This study provides framework interrogating how complex biological processes, such as antitumoral immunity, occur through concerted actions spatial domains.
Язык: Английский
Процитировано
712Cell, Год журнала: 2021, Номер 184(3), С. 596 - 614.e14
Опубликована: Янв. 27, 2021
Checkpoint inhibitors (CPIs) augment adaptive immunity. Systematic pan-tumor analyses may reveal the relative importance of tumor-cell-intrinsic and microenvironmental features underpinning CPI sensitization. Here, we collated whole-exome transcriptomic data for >1,000 CPI-treated patients across seven tumor types, utilizing standardized bioinformatics workflows clinical outcome criteria to validate multivariable predictors Clonal mutation burden (TMB) was strongest predictor response, followed by total TMB CXCL9 expression. Subclonal TMB, somatic copy alteration burden, histocompatibility leukocyte antigen (HLA) evolutionary divergence failed attain pan-cancer significance. Dinucleotide variants were identified as a source immunogenic epitopes associated with radical amino acid substitutions enhanced peptide hydrophobicity/immunogenicity. Copy-number analysis revealed two additional determinants supported prior functional evidence: 9q34 (TRAF2) loss response CCND1 amplification resistance. Finally, single-cell RNA sequencing (RNA-seq) clonal neoantigen-reactive CD8 tumor-infiltrating lymphocytes (TILs), combined bulk RNA-seq CPI-responding tumors, CCR5 CXCL13 T-cell-intrinsic markers sensitivity.
Язык: Английский
Процитировано
675Nature reviews. Immunology, Год журнала: 2021, Номер 22(4), С. 209 - 223
Опубликована: Июль 12, 2021
Язык: Английский
Процитировано
671Nature Reviews Genetics, Год журнала: 2021, Номер 22(10), С. 627 - 644
Опубликована: Июнь 18, 2021
Язык: Английский
Процитировано
670